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ostopenia in the mechanism of rapidly destructive hip osteoarthri-
tis. We confirm the presence of subchondral insufficiency fracture
in hip with RDA.
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S. Okamoto1, N. Ohtsu1, T. Okamoto1, A. Itabashi2,
H. Noguchi3, H. Suzuki4
1SORF Okamoto Clinic, Oita, Japan, 2Saitama Center of Bone
Researth, Saitama, Japan, 3Noguchi Thyroid Clinic and Hospital
Foundation, Beppu, Japan, 4Suzuki Orthodontic office,
Nagasaki, Japan
Purpose: Three-dimensional morphologic data of the osteo-
porotic and osteoarthritic spine has not been established.
Methods: We created computerized 3-D renderings of 1160
spines comprised of post-menoposal women aged 45-85, pri-
marily of patients of osteoporosis and osteoarthritis, and healthy
female controls aged 20-40. The digital 3-D models were con-
structed from helical CT data and examined for morphologic
characteristics.
Results: Close examination of the 3-D models revealed that
the vertebral endplates of post-menopausal women are rarely
smooth and are frequently compromised with perforated indenta-
Fig. 1. Perforation to endplate area ratio and years after menopause.
Fig. 2
tions, or Schmorl’s nodes. These could possibly act as openings
through which pressure-induced escape of the disk nucleus
could occur, and suggests that disk herniation into the weakened
vertebral body through the perforated endplates can cause OA-
inducing instability in the same manner as the lateral slippage of
the disk.
We further calculated the ratio of the perforations to the area
of the endplates and found that the there was a significant
correlation between the perforation/endplate area ratio and the
number of years after menopause.
Conclusions: Close examination of 3-D renderings of the os-
teoporotic vertebrae revealed that the vertebral endplates of
post-menopausal women are often compromised with indenta-
tions and perforations whose ratio to the area of the endplates
increase with years after menopause. In at least some of the
cases, the apparent narrowing of the intervertebral space result-
ing in the contact of the vertebral rims and the subsequent OA
changes, in what has conventionally been known as fish-shaped
vertebral fractures, may in fact be secondary to the herniation
of the disk nucleus into the weakened vertebral body of the
osteoporotic spine.
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Purpose: Previous investigations have presented conflicting evi-
dence concerning a potential association between gynaecologic
and reproductive factors and osteoarthritis (OA). Support for a
hormonal association with OA comes from retrospective stud-
ies suggesting that women who have had a surgically induced
menopause have a 2-fold increase for the risk of OA when com-
pared with controls. Conflicting reports from previous studies
have suggested both positive and negative effects of hormone
replacement therapy (HRT) on the incidence of OA following
hysterectomy. The aim of this investigation was to determine
whether self-reported OA is associated with total hysterectomy
and/or HRT use in a large cohort of women.
Methods: Between 1990-1994, 5119 women, aged between
49-54 years (mean 48.5±2.3)) were recruited randomly from a
community health index for the Aberdeen Prospective Osteo-
porosis Screening Study (APOSS). Each was weighed, their
height measured and asked questions relating to bone disease,
menopausal status, hysterectomy, hormone replacement therapy
(HRT), and current smoking. 223 participants self-reported OA
while 4896 did not. Between 1997-2000, 3883 women (mean
age 54.8±2.2) returned for a 2nd visit and underwent similar
investigations. At this visit 687 women self-reported OA.
Results: Women with OA were significantly (p<0.001) heavier at
baseline 68.73±0.53 kg and follow-up 71.80±0.55 kg visits than
those without OA; baseline 65.40±0.23 kg, follow-up 68.00±0.24
kg. Preliminary results indicate that the risk of OA was signifi-
cantly higher among women who had had a hysterectomy or who
had stopped HRT. After adjustment for potential confounding fac-
tors such as age and weight, the odds ratios (95% confidence
intervals) of OA among all hysterectomized women compared
with controls was 1.34 (1.08, 1.66) (p=0.007). For women who
had previously taken HRT but stopped, the odds ratio for re-
porting OA (95% CI) was 1.57 (1.28, 1.95), p=0.01. There was
no increased risk in current HRT users, OR:1.13 (0.93, 1.39),
p=0.22.
Conclusions: In this population, a hysterectomy or ceasing
HRT treatment was associated with an increase in self-reported
OA. However, whether these factors are directly involved in the
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aetiology of the disease or are associated with other underlying
and confounding factors will require further studies.
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Purpose: Osteoarthritis (OA) is a leading cause of disability
in the elderly. European recommendations (EULAR) for the
treatment of knee OA (KOA) were updated in 2003. Optimal
management requires a combination of non pharmacological
treatment (NP) and pharmacological treatment, paracetamol (ac-
etaminophen)(APAP) being the oral analgesic to try first and, if
successful, the preferred long term oral analgesic.
The aim of this study was to evaluate, in general practitioners
(GPs), the first line therapeutic strategy evolution in patients (pts)
with painful KOA over a 1-year (yr) period and whether it is in
line with EULAR recommendations.
Methods: This was an observational, prospective, multicenter
1-yr cohort study conducted in France (Fr) and Spain (Sp), with
follow-up visits at months (M) 3, 6, 9 and 12. Pts were aged
over 50 yr, suffering from painful KOA clinically defined (ACR
criteria), not treated within the previous 6 months and for whom
the GP planned to initiate a first line treatment based on EULAR
recommendations.
Results: 383 randomly selected GPs (Fr: 190/Sp: 193) included
a total of 1075 pts (Fr 576/Sp 499). Baseline pts characteristics
in Fr and Sp were similar: overall mean (SD) age 68 (10) yr,
BMI 29 (5) kg/m2, OA duration 5 (6) yr, 743 (69%) females.
Of the selected 1075 pts, 933 (87%) completed the 1-yr follow-
up. Clinical characteristics at M0 (baseline) and M12 for all pts
selected and for pts having completed the 1-yr follow-up are
provided in table 1. Considering the 933 pts who completed the
1-yr follow-up: 925 (99%) had at least one APAP prescription
over this period, 897 (96%) were prescribed APAP at M0, 766
(82%) at M12 and 665 (71%) continuously received APAP without
interruption over the 1-yr period. 437 (47%) were prescribed a
treatment strictly according the Eular recommendations at M0
(i.e. APAP as monotherapy associated with NP). Among them,
143 (33%) complied over the 1-yr period, 128 (29%) stopped
NP, 84 (19%) required additional pharmacological treatment, 44
Table 1. Pts clinical characteristics at baseline (M0) and at one year (M12)
Pts selected Pts having completed
at M0 the 1-yr follow-up
M0 (n=1075) M0 (n=933) M12 (n=933)
Pain intensity (pts %)
No pain/Mild 3.6 3.5 54.6
Moderate 44.1 43.9 35.9
Severe/Extreme 52.4 52.5 9.5
Clinical signs (pts %)
Night pain (a) 49.2 49.4 16.7
Morning stiffness
(duration; min) (b) 82.9 (25) 83.4 (25) 53.9 (18)
Sudden pain increase (c) 71.7 72.4 12.6
Knee effusion (d) 16.9 17.5 4.2
4 signs (a+b+c+d) 7.0 7.3 1.9
(5%) stopped APAP. Clinical signs globally improved over the 1-yr
period: the % of pts with moderate to extreme pain decreased
from 96% at M0 to 45% at M12 and the % of pts with signs of
inflammation substantially decreased (Table 1).
Conclusions: This study provides major information on the long
term management of pts with painful KOA in clinical practice.
Nonpharmacological treatments remain insufficiently prescribed
and, when initiated, are rarely continued over the long term.
On the other hand, first line pharmacological treatment with
APAP was initiated for 96% pts and was well followed, 71% pts
continuing APAP over the 1-yr period. Under these therapeutic
conditions, after a 1-yr treatment period, improvement in pain,
stiffness and clinical signs of inflammation was clinically relevant.
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Purpose: To evaluate the presence of joint effusion in knee
suprapatellar recess by means of sonography in 50 patients with
osteoarthritis (OA) attending an external rheumatology consulta-
tion and to correlate it with values of pain and functional capacity
presented by these patients as measured by visual analogue
scale (VAS) and Lequesne index respectively.
Methods: The study included 50 consecutive patients attending
an external rheumatology consultation, diagnosed with uni or
bilateral gonarthrosis according to ACR criteria. Data monitor-
ing included: age (mean: 61), sex (37 women, 13 men), BMI
(mean: 30), VAS (mean: 6), Lequesne index (less than 6: 25
patients/between 6 and 11: 24 patients/more than 11: 1 patient),
radiological involvement according to Kellgren and Lawrence
scale (grade II: 20, grade III: 25, grade IV: 5) and presence of
joint effusion (minimum: 10 patients/moderate: 4 patients/severe:
1 patient).
The sonographic evaluation was conducted by a single
sonography-expert rheumatologist and the patients were always
assessed in the same position: supine decubitus with 30° flexion
of the extremity. Joint effusion was considered to be present
when sonography showed a hypoechogenic or an anechogenic
collection displaceable and compressible by the probe pressure
with an anteroposterior diameter bigger than 4 mm. The pres-
ence of joint effusion was measured by a semiquantitative scale:
minimum, moderate and severe. In case of bilateral involvement,
the most symptomatic knee was evaluated.
Results: Results are shown in the table below:
Table 1
Joint effusion VAS Lequesne Grade II Grade III Grade IV
OA OA OA
Minimum10 patients 4 ± 1 5 ± 1 5 5 –
Moderate4 patients 6 ± 1 8 ± 1 2 2 –
Severe1 patient 8 ± 1 11 ± 1 – – 1
Conclusions: Among the 50 patients with symptomatic os-
teoarthritis studied, 15 presented joint effusion as measured
by sonography.
Severity of joint effusion correlated with higher levels of pain
(VAS) and functional incapacity (Lequesne index), though not
with more advanced radiological grades of osteoarthritis.
